This study not only demonstrated the exciting therapeutic effect of ASO 10–27 but also suggested that the rescue of SMN expression in peripheral tissues was necessary for the treatment of SMA, opening a new avenue in academic research. Here, SMN1 is linked to proximal spinal muscular atrophy.